CDKN1A and neoplasm: The disappearance of pAKT, the decrease in c-MYC, together with the upregulation of p21 and the decrease in Ki-67, collectively indicate that a potential shift toward reduced proliferation and cell cycle arrest occurred in the tumor following the indicated therapeutic combination.